In this series, we examine what happens after the proof of concept and how AI becomes part of the software delivery pipeline.
The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback